- Home
- ZLAB vs TPH Comparison
ZLAB vs TPH Comparison
Compare ZLAB & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- TPH
- Stock Information
- Founded
- ZLAB 2013
- TPH 2009
- Country
- ZLAB China
- TPH United States
- Employees
- ZLAB N/A
- TPH N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- TPH Homebuilding
- Sector
- ZLAB Health Care
- TPH Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- TPH Nasdaq
- Market Cap
- ZLAB 3.6B
- TPH 2.9B
- IPO Year
- ZLAB 2017
- TPH N/A
- Fundamental
- Price
- ZLAB $30.14
- TPH $29.49
- Analyst Decision
- ZLAB Buy
- TPH Strong Buy
- Analyst Count
- ZLAB 4
- TPH 5
- Target Price
- ZLAB $47.37
- TPH $42.80
- AVG Volume (30 Days)
- ZLAB 944.8K
- TPH 1.0M
- Earning Date
- ZLAB 05-08-2025
- TPH 07-24-2025
- Dividend Yield
- ZLAB N/A
- TPH N/A
- EPS Growth
- ZLAB N/A
- TPH 20.35
- EPS
- ZLAB N/A
- TPH 4.51
- Revenue
- ZLAB $418,326,000.00
- TPH $4,294,395,999.00
- Revenue This Year
- ZLAB $44.07
- TPH N/A
- Revenue Next Year
- ZLAB $49.13
- TPH $7.76
- P/E Ratio
- ZLAB N/A
- TPH $6.53
- Revenue Growth
- ZLAB 43.72
- TPH 10.82
- 52 Week Low
- ZLAB $16.01
- TPH $27.90
- 52 Week High
- ZLAB $39.77
- TPH $47.78
- Technical
- Relative Strength Index (RSI)
- ZLAB 46.27
- TPH 40.54
- Support Level
- ZLAB $30.11
- TPH $29.44
- Resistance Level
- ZLAB $31.34
- TPH $30.66
- Average True Range (ATR)
- ZLAB 1.09
- TPH 0.75
- MACD
- ZLAB 0.07
- TPH -0.21
- Stochastic Oscillator
- ZLAB 43.07
- TPH 4.87
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.